Vogenx, Inc.

VOGX chart

Vogenx, Inc. news

• Vogenx Inc Estimates – NASDAQ:VOGX

  TradingView · Oct 23, 5:43 PM EDT

• Vogenx Launches Phase 2b EMERGE Trial of Oral Mizagliflozin for Post-Bariatric Hypoglycemia

  BioBuzz · Oct 22, 11:48 AM EDT

• Why is Vogenx stock climbing 6% today? By Investing.com

  Investing.com Nigeria · Oct 22, 9:09 AM EDT

• 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  Benzinga · Oct 22, 8:05 AM EDT

• 12 Health Care Stocks Moving In Wednesday's After-Market Session

  Benzinga · Oct 21, 5:05 PM EDT

• Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia

  Yahoo Finance · Oct 15, 4:35 PM EDT

• Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer

  Yahoo Finance · Oct 9, 8:00 AM EDT

• Vogenx Appoints Ken Toombs to Board of Directors

  Yahoo Finance · Sep 22, 9:00 AM EDT

• Federal Filings Joins Client Vogenx at the Nasdaq Opening Bell

  Yahoo Finance · Aug 24, 7:00 PM EDT

• Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering

  Yahoo Finance · Aug 17, 12:25 PM EDT

• Vogenx Announces Closing of Initial Public Offering

  Yahoo Finance · Aug 13, 4:35 PM EDT

Vogenx, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-KFORM 8-K2026-10-09
• 8-KFORM 8-K2026-09-22
• 10-QFORM 10-Q2026-09-17
• 8-KFORM 8-K2026-08-19
• 8-KFORM 8-K2026-08-13
• S-1FORM S-12026-07-15

About Vogenx, Inc.

Ticker

VOGX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Raleigh, NC

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1903784

Frequently asked questions